Neuroprotection of taurine against bilirubin-induced elevation of apoptosis and intracellular free calcium ion in vivo

References

• Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G, Mocchetti I. 2001. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 21:3104–3112.
   PubMed Web of Science ®Google Scholar
• Bhutani VK, Johnson L. 2009. Kernicterus in the 21st century: frequently asked questions. J Perinatol 29(Suppl 1):20–24.
   PubMedGoogle Scholar
• Birdsall TC. 1998. Therapeutic applications of taurine. Altern Med Rev 3:128–136.
   PubMedGoogle Scholar
• Brosnan JT, Brosnan ME. 2006. The sulfur-containing amino acids: an overview. J Nutr 136:1636S–1640S.
   PubMed Web of Science ®Google Scholar
• Du Y, Dodel RC, Bales KR, Jemmerson R, Hamilton-Byrd E, Paul SM. 1997. Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J Neurochem 69:1382–1388.
   PubMed Web of Science ®Google Scholar
• Grojean S, Koziel V, Vert P, Daval JL. 2000. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp Neurol 166:334–341.
   PubMed Web of Science ®Google Scholar
• Hagar HH. 2004. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 151:335–343.
   PubMed Web of Science ®Google Scholar
• Hankø E, Hansen TW, Almaas R, Rootwelt T. 2006. Recovery after short-term bilirubin exposure in human NT2-N neurons. Brain Res 1103:56–64.
   PubMed Web of Science ®Google Scholar
• Johnson LH, Bhutani VK, Brown AK. 2002. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 140:396–403.
   PubMed Web of Science ®Google Scholar
• Kruman II, Wersto RP, Cardozo-Pelaez F, Smilenov L, Chan SL, Chrest FJ, Emokpae R Jr, Gorospe M, Mattson MP. 2004. Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41:549–561.
   PubMed Web of Science ®Google Scholar
• Morales I, Dopico JG, Sabate M, Gonzalez-Hernandez T, Rodriguez M. 2007. Substantia nigra osmoregulation: taurine and ATP involvement. Am J Physiol, Cell Physiol 292:C1934–C1941.
   Web of Science ®Google Scholar
• Okuda T, Kadotsuji K, Takayama C, Hanada K, Mukaizawa F, Ogawara K, Higaki K, Kimura T. 2006. Involvement of intracellular Ca2+ dynamics in cytoprotective action by amino acids and cytotoxicity by sodium laurate, an absorption enhancer. J Pharm Sci 95:2256–2265.
   PubMed Web of Science ®Google Scholar
• Palackal T, Moretz R, Wisniewski H, Sturman J. 1986. Abnormal visual cortex development in the kitten associated with maternal dietary taurine deprivation. J Neurosci Res 15:223–239.
   PubMed Web of Science ®Google Scholar
• Paredes RM, Etzler JC, Watts LT, Zheng W, Lechleiter JD. 2008. Chemical calcium indicators. Methods 46:143–151.
   PubMed Web of Science ®Google Scholar
• Paula-Lima AC, De Felice FG, Brito-Moreira J, Ferreira ST. 2005. Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology 49:1140–1148.
   PubMed Web of Science ®Google Scholar
• Pion PD, Kittleson MD, Rogers QR, Morris JG. 1987. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764–768.
   PubMed Web of Science ®Google Scholar
• Rodrigues CM, Solá S, Silva R, Brites D. 2000. Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization. Mol Med 6:936–946.
   PubMed Web of Science ®Google Scholar
• Sakhi S, Sun N, Wing LL, Mehta P, Schreiber SS. 1996. Nuclear accumulation of p53 protein following kainic acid-induced seizures. Neuroreport 7:493–496.
   PubMed Web of Science ®Google Scholar
• Sturman JA. 1993. Taurine in development. Physiol Rev 73:119–147.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Ohyabu Y, Takahashi K, Solodushko V, Takatani T, Itoh T, Schaffer SW, Azuma J. 2003. Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes. J Cardiovasc Pharmacol 41:726–733.
   PubMed Web of Science ®Google Scholar
• Tenneti L, Lipton SA. 2000. Involvement of activated caspase-3-like proteases in N-methyl-d-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem 74:134–142.
   PubMed Web of Science ®Google Scholar
• Uberti D, Belloni M, Grilli M, Spano P, Memo M. 1998. Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Eur J Neurosci 10:246–254.
   PubMed Web of Science ®Google Scholar
• Wu T, Ding XS, Wang W, Wu J. 2006. MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one) attenuated simulated ischemia/reperfusion injury in cultured rat hippocampal cells. Biol Pharm Bull 29:1613–1617.
   PubMed Web of Science ®Google Scholar
• Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA, Morrison RS. 1996. Evidence for p53-mediated modulation of neuronal viability. J Neurosci 16:6753–6765.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yang X, Gao X. 2010. Taurine protects against bilirubin-induced neurotoxicity in vitro. Brain Res 1320:159–167.
   PubMed Web of Science ®Google Scholar